G. Dores

发表

Retrospective benzene exposure assessment for a multi-center case-cohort study of benzene-exposed workers in China

R. Hayes, N. Rothman, R. Vermeulen, 2016, Journal of Exposure Science and Environmental Epidemiology.

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Farin Kamangar, W. Anderson, F. Kamangar, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast Cancer Risk Following Radiotherapy for Hodgkin Lymphoma: Modification by Other Risk Factors. Running Head: Breast cancer following HL radiotherapy

M. Stovall, H. Storm, M. Gospodarowicz, 2005 .

Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.

M. Stovall, H. Storm, M. Gospodarowicz, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

“Second Malignant Neoplasms Among Long-Term Survivors of Hodgkinʼs Disease: A Population-Based Evaluation Over 25 Years”

C. Metayer, G. Dores, R. Curtis, 2002 .

Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12

S. Devesa, L. Morton, M. Linet, 2016, British journal of haematology.

Risk of therapy-related myelodysplastic syndrome/acute myeloid leukemia after childhood cancer: a population-based study

S. Chanock, M. Tucker, L. Morton, 2019, Leukemia.

Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.

M. Tucker, J. Fraumeni, K. Onel, 2013, Blood.

Mutations in Leukemia and Myelodysplastic Syndrome after Ovarian Cancer 1

P. Hall, B. Kohler, D. Slater, 2002 .

p53 mutations in leukemia and myelodysplastic syndrome after ovarian cancer.

P. Hall, B. Kohler, D. Slater, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database

G. Dores, P. Saunders-Hastings, A. Shoaibi, 2021, PloS one.

Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.

L. Morton, M. Linet, G. Dores, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Incidence of potentially human papillomavirus–related neoplasms in the United States, 1978 to 2007

S. Devesa, A. Chaturvedi, G. Dores, 2013, Cancer.

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

M. Gail, M. Stovall, H. Storm, 2005, Journal of the National Cancer Institute.

The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma.

C. Flowers, L. Morton, D. Chihara, 2021, Blood.

Cause‐specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001–2017

L. Morton, M. Linet, G. Dores, 2021, American journal of hematology/oncology.

Small Intestinal Cancer: a Population-Based Study of Incidence and Survival Patterns in the United States, 1992 to 2006

S. Devesa, G. Dores, M. Huycke, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms

J. Fraumeni, S. Devesa, J. Toro, 2008, Cancer.

S. Chanock, M. Tucker, J. Sampson, 2022, JAMA network open.

Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data

G. Dores, H. Izurieta, M. Niu, 2020, Cancer.

Clinical Investigation : Gynecologic Cancer Radiation Dose and Subsequent Risk for Stomach Cancer in Long-term Survivors of Cervical Cancer

P. Hall, H. Joensuu, M. Stovall, 2013 .

Cutaneous lymphomas reported to the National Cancer Institute's surveillance, epidemiology, and end results program: applying the new WHO-European Organisation for Research and Treatment of Cancer classification system.

S. Devesa, W. Anderson, G. Dores, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Letter to the Editor: Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma

M. Tucker, J. Fraumeni, J. Warren, 2015, Leukemia.

Benzene exposure and risk of benzene poisoning in Chinese workers

N. Rothman, R. Vermeulen, Q. Lan, 2022, Occupational and Environmental Medicine.

Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992–2004

K. McGlynn, S. Devesa, M. Linet, 2009, British journal of haematology.

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy

J. Fraumeni, W. Anderson, G. Dores, 2010, British Journal of Cancer.

Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration.

Tatiana M. Prowell, G. Dores, Kathleen M Sullivan, 2022, JAMA Oncology.

Merkel Cell Carcinoma and Multiple Primary Cancers

W. Anderson, L. Travis, G. Dores, 2006, Cancer Epidemiology Biomarkers & Prevention.

Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

S. Devesa, G. Dores, M. Huycke, 2010, Journal of the American Academy of Dermatology.

Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017.

G. Dores, P. Haber, John R Su, 2019, Vaccine.

Incidence of Carcinoma of the Major Salivary Glands According to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States

C. Land, G. Dores, R. Curtis, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Risk of radiation‐related salivary gland carcinomas among survivors of Hodgkin lymphoma

E. Ron, M. Stovall, G. Dores, 2008, Cancer.

Risk of treatment-related esophageal cancer among breast cancer survivors.

P. Hall, S. Fosså, J. Fraumeni, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.

John D Boice, Eero Pukkala, Per Hall, 2005, Journal of the National Cancer Institute.

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.

M. Stovall, H. Storm, M. Gospodarowicz, 2003, JAMA.

Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.

M. Tucker, E. Engels, L. Morton, 2019, Blood advances.

Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel

G. Dores, M. Niu, S. Perez-Vilar, 2021, American journal of hematology.

Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis

D. Weisenburger, D. Richardson, R. Field, 2007, British journal of haematology.

Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma

P. Hall, S. Fosså, J. Fraumeni, 2014, Haematologica.

Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era

M. Tucker, L. Morton, M. Linet, 2019, JAMA oncology.

Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site

D. Weisenburger, S. Devesa, L. Morton, 2014, British journal of haematology.

Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology

S. Devesa, W. Anderson, M. Linet, 2007, British journal of haematology.

Stomach cancer risk after treatment for hodgkin lymphoma.

P. Hall, S. Fosså, J. Fraumeni, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival

M. Tucker, D. Withrow, L. Morton, 2018, Journal of the National Cancer Institute.

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.

Heikki Joensuu, Eero Pukkala, Per Hall, 2006, Journal of the National Cancer Institute.

Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007.

S. Devesa, L. Morton, M. Linet, 2012, Blood.

Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma.

P. Hall, S. Fosså, F. Langmark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

M. Stovall, H. Storm, M. Gospodarowicz, 2005, Blood.

Melanoma of the skin and laterality.

S. Devesa, G. Dores, M. Huycke, 2011, Journal of the American Academy of Dermatology.

Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States

J. Fraumeni, J. Toro, E. Lanoy, 2009, AIDS.

Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans

L. Morton, M. Linet, G. Dores, 2011, Cancer.

Noncancer causes of death in survivors of testicular cancer.

P. Hall, Jinbo Chen, S. Fosså, 2007, Journal of the National Cancer Institute.

Increased stomach cancer risk following radiotherapy for testicular cancer

P. Hall, S. Fosså, J. Fraumeni, 2014, British Journal of Cancer.

Evaluating Research Training Outcomes: Experience from the Cancer Prevention Fellowship Program at the National Cancer Institute

D. Weed, V. Berger, S. Perkins, 2006, Academic medicine : journal of the Association of American Medical Colleges.

Adapting Postdoctoral Training to Interdisciplinary Science in the 21st Century: The Cancer Prevention Fellowship Program at the National Cancer Institute

D. Weed, S. Perkins, G. Dores, 2005, Academic medicine : journal of the Association of American Medical Colleges.

Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.

M. Tucker, J. Fraumeni, J. Warren, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatic cancer risk after treatment of Hodgkin lymphoma.

P. Hall, S. Fosså, J. Fraumeni, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study

W. Anderson, G. Dores, R. Curtis, 2010, Breast Cancer Research.

Epidemiology and Hereditary Aspects of Acute Leukemia

S. Devesa, L. Morton, M. Linet, 2013 .

A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992–2010

S. Devesa, G. Dores, B. Ghabach, 2015, BMC Cancer.

Comparison of Age Distribution Patterns for Different Histopathologic Types of Breast Carcinoma

M. Sherman, R. Pfeiffer, W. Anderson, 2006, Cancer Epidemiology Biomarkers & Prevention.

Hairy cell leukaemia: a heterogeneous disease?

D. Weisenburger, P. Rosenberg, R. Matsuno, 2008, British journal of haematology.

Stomach Cancer Following Hodgkin Lymphoma, Testicular Cancer and Cervical Cancer: A Pooled Analysis of Three International Studies with a Focus on Radiation Effects

P. Hall, S. Fosså, F. Langmark, 2017, Radiation Research.

A retrospective cohort study of cause‐specific mortality and incidence of hematopoietic malignancies in Chinese benzene‐exposed workers

N. Rothman, R. Vermeulen, Q. Lan, 2015, International journal of cancer.

Cause‐specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000–2016

L. Morton, M. Linet, G. Dores, 2020, British journal of haematology.

Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case-Cohort Study.

R. Hayes, N. Rothman, R. Vermeulen, 2018, Journal of the National Cancer Institute.

Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000–2014

C. Ronckers, A. Berrington de González, F. V. van Leeuwen, 2018, Leukemia.

Benzene exposure-response and risk of lymphoid neoplasms in Chinese workers: A multicenter case-cohort study.

R. Hayes, N. Rothman, Q. Lan, 2020, American journal of industrial medicine.

Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion

B. Goldstein, J. Hurst, G. Dores, 2023, Drug Safety.

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

G. Morgan, H. Storm, J. Allan, 2007, Journal of Medical Genetics.

Increased pancreatic cancer risk following radiotherapy for testicular cancer

P. Hall, S. Fosså, F. Langmark, 2016, British Journal of Cancer.

cer Surveillance Research all Intestinal Cancer : a Population-Based Study of dence and Survival Patterns in the B & P ted States , 1992 to 2006

S. Devesa, G. Dores, M. Huycke, 2010 .

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017

G. Dores, S. Perez-Vilar, Marthe Bryant-Genevier, 2019, JAMA network open.

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

G. Dores, Connie Cheng, Afrouz Nayernama, 2022, American journal of hematology.

Safety Surveillance of Bivalent Meningococcal Group B Vaccine, Vaccine Adverse Event Reporting System, 2014-2018.

G. Dores, J. Duffy, John R Su, 2020, Open forum infectious diseases.

Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019

G. Dores, M. Niu, Shaokui Wei, 2021, Drugs - Real World Outcomes.

Long-term cause-specific mortality among 41,146 one-year survivors of Hodgkin lymphoma (HL)

P. Hall, Jinbo Chen, S. Fosså, 2005 .

Immune globulin usage trends in commercially insured and Medicare populations, 2009–2019

D. Scott, T. MaCurdy, G. Dores, 2023, Transfusion.

Safety review of tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccines (Tdap) in adults aged ≥65 years, Vaccine Adverse Event reporting System (VAERS), United States, September 2010-December 2018.

G. Dores, P. Haber, M. Cano, 2019, Vaccine.

Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016-June 2018.

G. Dores, P. Haber, Paige W. Lewis, 2019, Vaccine.

Assessment of delayed reporting of mycosis fungoides and Sezary syndrome in the United States.

W. Anderson, G. Dores, M. Demierre, 2008, Archives of dermatology.

Physicians as citizens.

D. Weed, G. Dores, 2004, JAMA.

Bimodal breast cancer incidence patterns provide support for a dualistic model of mammary carcinogenesis.

M. Sherman, R. Pfeiffer, W. Anderson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018

L. Morton, M. Linet, G. Dores, 2023, EClinicalMedicine.

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System

G. Dores, M. Niu, S. Perez-Vilar, 2019, Journal of Pharmaceutical Health Care and Sciences.

Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976-2005

A. García, S. Devesa, G. Dores, 2010 .

Influence of hormones on platelet intracellular calcium.

Marilyn E. Miller, S. Thorpe, M. Miller, 1995, Thrombosis research.

Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions.

Marilyn E. Miller, S. Thorpe, M. Miller, 1994, Thrombosis research.

Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.

G. Dores, J. Duffy, M. Cano, 2021, Vaccine.

U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome.

G. Dores, Afrouz Nayernama, S. Camilli, 2022, Clinical lung cancer.

Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017

G. Dores, Marthe Bryant-Genevier, Silvia Perez-Vilar, 2019, JAMA network open.

Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans

L. Morton, M. Linet, G. Dores, 2011, Cancer.

Radiation dose and subsequent risk for stomach cancer in long-term survivors of cervical cancer.

H. Joensuu, M. Stovall, H. Storm, 2013, International journal of radiation oncology, biology, physics.